{Reference Type}: Journal Article
{Title}: The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review.
{Author}: Dettrick A;Foden N;Hogan D;Azer M;Blazak J;Atwell D;Buddle N;Min M;Livingston R;Banney L;Donkin R;
{Journal}: Pathology
{Volume}: 56
{Issue}: 5
{Year}: 2024 Aug 28
{Factor}: 5.335
{DOI}: 10.1016/j.pathol.2024.05.002
{Abstract}: Deaths from non-melanoma skin cancers (NMSCs) have almost doubled in Australia in recent years. Cutaneous squamous cell carcinoma (cSCC) constitutes approximately 20% of NMSCs, but is responsible for most of the deaths. Most skin cancers are easy to diagnose and treat and therefore cSCC are often trivialised; however, there is a high-risk subgroup of cSCC (HRcSCC) that is associated with a high risk of metastasis and death. The definition of early HRcSCC and our ability to identify them is evolving. Many significant prognostic factors have been identified, but a universally accepted prognostic index does not exist. Guidelines for workup, treatment, and follow-up leave many important decisions open to broad interpretation by the treating physician or multidisciplinary team. Some of the treatments used for metastatic cSCC are not supported by robust evidence and the prognosis of metastatic cSCC is guarded. In this review, we highlight the rapid rise in NMSC deaths and discuss some of the deficiencies in our knowledge of how to define, diagnose, stage, and manage HRcSCC.